print
gohome
Print Edition
Teva 2 weeks from closing Ivax deal
Avi Krawitz
12/26/2005
Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company.
Teva Pharmeceutical Industries said Sunday it expects to close its acquisition of Ivax Corporation by January 12. Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company. The companies said they have signed a consent order for submission to the US Federal Trade Commision (FTC) which is "the last remaining regulatory condition to the consummation of the transaction."
print gohome
JPost.com: Arab-Israeli Conflict | Israel News | Diaspora | Middle East | Opinion | Premium | Blogs | Not Just News | Edition Francaise | Green Israel

Copyright © 2014 Jpost Inc. All rights reserved • Terms of UsePrivacy Policy